Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SOLIGENIX, INC. Director's Dealing 2012

Jul 25, 2012

35119_dirs_2012-07-25_05268019-b7e8-4445-b095-e8bff902c66e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SOLIGENIX, INC. (SNGX)
CIK: 0000812796
Period of Report: 2012-06-21

Reporting Person: Brownlie Keith L (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-06-21 Stock Option (Right to Buy) $0.30 A 25000 Acquired 2022-06-20 Common Stock (25000) Direct

Footnotes

F1: The option vests in installments of 6,250 shares on each of September 21, 2012, December 21, 2012, March 21, 2012 and June 21, 2012. The exercise price of the option equals $0.30 per share, the market price of the Company's common stock as of the close of business on June 21, 2012.